Creating advanced models for understanding biomolecular interactions and drug design
Open data-driven infrastructure for building biomolecular force fields for predictive biophysics and drug design
This study is working on better ways to understand how tiny molecules interact with larger biological structures, which can help create new and improved medicines for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-10580156 on NIH RePORTER |
What this research studies
This research focuses on developing accurate physical models to understand how small molecules interact with biological macromolecules, which is crucial for designing new therapeutics. The project aims to bridge existing gaps in technology by creating an open infrastructure that allows researchers to build and improve these models using automated machine learning methods. Additionally, it will compile machine-readable datasets to facilitate the development of next-generation force fields and employ Bayesian inference techniques for more reliable predictions. Patients may benefit from improved drug design and therapeutic options resulting from this advanced modeling.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new therapeutics developed through advanced biomolecular modeling.
Not a fit: Patients with conditions that are not addressed by the specific drugs or therapies developed from this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted drug therapies for various diseases.
How similar studies have performed: Other research has shown success in using advanced modeling techniques for drug design, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Shirts, Michael R — University of Colorado
- Study coordinator: Shirts, Michael R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.